title: Response to: Important Considerations When Determining the Cost-effectiveness of Viscosupplements in the Treatment of Knee Osteoarthritis.
authors: Department of Orthopaedics and Rehabilitation, New York Presbyterian Queens, New York, USA. rosenje@nyp.org.|Department of Orthopaedic Surgery and Rehabilitation, Weill Medical College of Cornell University, New York, USA. rosenje@nyp.org.
authors: Jeffrey
authors: J
authors: Rosen
authors: Sancheti Institute for Orthopaedics and Rehabilitation, Pune, Maharashtra, India.
authors: Parag
authors: P
authors: Sancheti
authors: Ferring Pharmaceuticals Inc., Parsippany, NJ, USA.
authors: Anke
authors: A
authors: Fierlinger
authors: Ferring Pharmaceuticals Inc., Parsippany, NJ, USA.
authors: Faizan
authors: F
authors: Niazi
authors: Division of Orthopaedics, Department of Surgery, Centre for Evidence-Based Orthopaedics, McMaster University, Hamilton, ON, USA.
authors: Herman
authors: H
authors: Johal
authors: Department of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI, USA.
authors: Asheesh
authors: A
authors: Bedi
mesh_terms: D003362:Cost-Benefit Analysis; D006801:Humans; D006820:Hyaluronic Acid; D007270:Injections, Intra-Articular; D020370:Osteoarthritis, Knee; D055675:Viscosupplements
chemical_list: D055675:Viscosupplements; D006820:Hyaluronic Acid